title: Biosimilar makers flout forced patent negotiations in US.
authors: Cassandra
authors: C
authors: Willyard
mesh_terms: D059451:Biosimilar Pharmaceuticals; D004345:Drug Industry; D006801:Humans; D017008:Negotiating; D010330:Patents as Topic; D058991:Patient Protection and Affordable Care Act; D014481:United States
chemical_list: D059451:Biosimilar Pharmaceuticals